Life Science Companies are Litigation Targets for Unhappy Investors Post author:Sam Post published:February 22, 2018 Post category:BioPharma Life science companies are popular targets for securities fraud litigation. Source: BioSpace You Might Also Like AcelRx Stopped Cold: FDA Rejects NDA for Pain Drug Dsuvia (ARX-04) October 11, 2017 Theratechnologies Announces New Findings With The Investigational Antiretroviral Ibalizumab And With EGRIFTA (Tesamorelin For Injection) July 23, 2017 CureMatch Partnering With Patient Power To Educate And Empower Patients And Oncologists Regarding Personalized Cancer Treatments March 29, 2017
Theratechnologies Announces New Findings With The Investigational Antiretroviral Ibalizumab And With EGRIFTA (Tesamorelin For Injection) July 23, 2017
CureMatch Partnering With Patient Power To Educate And Empower Patients And Oncologists Regarding Personalized Cancer Treatments March 29, 2017
